Dexcom (DXCM) Consolidated Net Income (2010 - 2026)

Dexcom (DXCM) has reported Consolidated Net Income for 17 consecutive years, with $249.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Consolidated Net Income rose 38.54% year-over-year to $249.1 million in Q2 2026; TTM through Jun 2026 was $999.7 million, a 74.93% increase from a year earlier, with the FY2025 full-year figure at $836.3 million, up 45.14% from the prior year.
• Consolidated Net Income was $249.1 million for Q2 2026 at Dexcom, up from $199.5 million in the prior quarter.
• Over five years, Consolidated Net Income peaked at $283.8 million in Q3 2025 and troughed at $48.6 million in Q1 2023.
• A 5-year average of $152.4 million and a median of $139.0 million in 2024 frame the typical range for Consolidated Net Income.
• Across the five-year window, Consolidated Net Income soared 1832.08% in 2022 and tumbled 50.05% in 2023, its largest moves.
• Over 5 years, Consolidated Net Income stood at $91.8 million in 2022, then jumped by 179.19% to $256.3 million in 2023, then tumbled by 40.81% to $151.7 million in 2024, then soared by 76.2% to $267.3 million in 2025, then declined by 6.81% to $249.1 million in 2026.
• The last three Consolidated Net Income figures came in at $249.1 million (Q2 2026), $199.5 million (Q1 2026), and $267.3 million (Q4 2025), per Business Quant data.